Exos in pro-inflammatory M1-like macrophage-derived EVs blunts insulin sensitivity in target cells (64), which may be one of the reasons for the dysfunction of insulin signaling pathway in hepatocytes, thus helping hepatocellular carcinoma cells to build up resistance to drugs associated with insulin-sensitizing therapies. Here, INS is linked to hepatocellular carcinoma.